We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
3D Systems Develops Medical Simulator for Spine Surgery
Read MoreHide Full Article
3D Systems Corporation (DDD - Free Report) recently expanded its 3D precision portfolio, with the launch of Simbionix SPINE Mentor, a hands-on simulated training and practice tool for minimally invasive spine surgeries.
With the launch of this simulator, 3D Systems forayed into spinal surgery training. Based on the company’s simulation, 3D printing and medical tools, Simbionix SPINE Mentor is a hybrid solution that can cater to the needs of neurosurgeons, anesthesiologists, orthopedic and pain management surgeons. This will help the healthcare personnel to practice procedures.
The company believes that its latest training and practice tool is a superior alternative to cadaveric training, which comes with a small degree of realism. SPINE Mentor is capable of performing multiple procedures, including lumbar puncture, placement of catheters and wires. Also, it is well equipped to simulate real-time fluoroscopic image displays for the entire spine, which will eliminate the need for real fluoroscopy.
The company remains confident that unwillingness of medical institutions to use animals in training will continue to stoke demand for simulators. To make the most of changing times, 3D Systems has developed a spectrum of innovative solutions ranging from simulation to implants. It is strongly focusing on enhacing the healthcare portfolio, which has acted as its strongest profit churner in recent times.
Over the past six months, shares of 3D Systems have returned an admirable 31.9%, outperforming the Zacks categorized Computer-Mini industry’s average gain of 25.3%. At the very least, the company seems favorably positioned to capitalize on the booming 3D printing industry, which presents a lucrative long-term growth opportunity. Especially for the healthcare business, the company believes that consistent demand for printers and materials for medical and dental customers will continue to drive growth.
Despite the spectacular stock performance, the company is facing some strong short-term headwinds, which are hard to ignore. For quite some time now, 3D Systems sales have been hurting from waning demand for printers. During first-quarter 2017, lower printer sales continued to thwart top-line performance. For full-year 2016, total revenue from printers declined 21% and the weaknesses are yet to subside fully.
These products, applications and channels involve different gross profit margins that are vulnerable to substantial fluctuations depending upon the mix of product shipments. Other challenges, including economic slowdown, inflation, currency fluctuations and commodity prices vagaries, have also marred the performance of most players in the industry.
This Zacks Rank #4 (Sell) stock’s earnings estimates have moved south in the past couple of months, which indicate bearish analyst sentiments. The company’s Zacks Consensus Estimate for full-2017 earnings moved down from $0.39 to $0.26, over the last 60 days, backed by six downward estimate revisions versus none upward.
With four back-to-back beats, Applied Materials has an average positive surprise of 3.3% for the trailing four quarters.
Cohu has a striking earnings surprise history, with an impressive average positive surprise of 121.2% for the trailing four quarters, beating estimates all through.
Amkor Technology beat earnings estimates in three out of the trailing four quarters, at an average of 43.1%.
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.
Image: Bigstock
3D Systems Develops Medical Simulator for Spine Surgery
3D Systems Corporation (DDD - Free Report) recently expanded its 3D precision portfolio, with the launch of Simbionix SPINE Mentor, a hands-on simulated training and practice tool for minimally invasive spine surgeries.
With the launch of this simulator, 3D Systems forayed into spinal surgery training. Based on the company’s simulation, 3D printing and medical tools, Simbionix SPINE Mentor is a hybrid solution that can cater to the needs of neurosurgeons, anesthesiologists, orthopedic and pain management surgeons. This will help the healthcare personnel to practice procedures.
The company believes that its latest training and practice tool is a superior alternative to cadaveric training, which comes with a small degree of realism. SPINE Mentor is capable of performing multiple procedures, including lumbar puncture, placement of catheters and wires. Also, it is well equipped to simulate real-time fluoroscopic image displays for the entire spine, which will eliminate the need for real fluoroscopy.
The company remains confident that unwillingness of medical institutions to use animals in training will continue to stoke demand for simulators. To make the most of changing times, 3D Systems has developed a spectrum of innovative solutions ranging from simulation to implants. It is strongly focusing on enhacing the healthcare portfolio, which has acted as its strongest profit churner in recent times.
Over the past six months, shares of 3D Systems have returned an admirable 31.9%, outperforming the Zacks categorized Computer-Mini industry’s average gain of 25.3%. At the very least, the company seems favorably positioned to capitalize on the booming 3D printing industry, which presents a lucrative long-term growth opportunity. Especially for the healthcare business, the company believes that consistent demand for printers and materials for medical and dental customers will continue to drive growth.
Despite the spectacular stock performance, the company is facing some strong short-term headwinds, which are hard to ignore. For quite some time now, 3D Systems sales have been hurting from waning demand for printers. During first-quarter 2017, lower printer sales continued to thwart top-line performance. For full-year 2016, total revenue from printers declined 21% and the weaknesses are yet to subside fully.
These products, applications and channels involve different gross profit margins that are vulnerable to substantial fluctuations depending upon the mix of product shipments. Other challenges, including economic slowdown, inflation, currency fluctuations and commodity prices vagaries, have also marred the performance of most players in the industry.
This Zacks Rank #4 (Sell) stock’s earnings estimates have moved south in the past couple of months, which indicate bearish analyst sentiments. The company’s Zacks Consensus Estimate for full-2017 earnings moved down from $0.39 to $0.26, over the last 60 days, backed by six downward estimate revisions versus none upward.
Stocks to Consider
Some better-ranked stocks in the broader sector include Applied Materials, Inc. (AMAT - Free Report) , Cohu, Inc. (COHU - Free Report) and Amkor Technology, Inc. (AMKR - Free Report) . While Applied Materials and Cohu sport a Zacks Rank #1 (Strong Buy), Amkor holds a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
With four back-to-back beats, Applied Materials has an average positive surprise of 3.3% for the trailing four quarters.
Cohu has a striking earnings surprise history, with an impressive average positive surprise of 121.2% for the trailing four quarters, beating estimates all through.
Amkor Technology beat earnings estimates in three out of the trailing four quarters, at an average of 43.1%.
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.
One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>